Nanotherapy to Reshape the Tumor Microenvironment: A New Strategy for Prostate Cancer Treatment

Area of Science:

• Oncology
• Nanomedicine
• Cancer Biology

Background:

• Prostate cancer (PCa) is a leading global cancer in males.
• Androgen deprivation therapy (ADT) is standard, but hormone resistance leads to poor prognoses.
• The tumor microenvironment (TME) is increasingly recognized as a critical factor in PCa progression and treatment resistance.

Purpose of the Study:

• To review the characteristics of the PCa TME and side effects of conventional treatments.
• To highlight emerging nanotherapy strategies for PCa.
• To discuss the therapeutic mechanisms and TME effects of nanotherapies.

Main Methods:

• Literature review of PCa TME characteristics.
• Review of traditional PCa treatment side effects.
• Analysis of current nanotherapy approaches, mechanisms, and TME impact in PCa.

Main Results:

• Established PCa TME features and ADT limitations are detailed.
• Novel nanotherapy strategies demonstrate potential for targeting the PCa TME.
• Nanotherapies show promise in overcoming treatment resistance and improving therapeutic efficacy.

Conclusions:

• Nanotherapy presents a promising frontier for overcoming ADT resistance in prostate cancer.
• Understanding TME interactions is key to developing effective nanomedicine strategies.
• Further research is expected to accelerate the clinical application of nanotherapy for PCa.